Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial

Post time 5 day(s) ago

journal：Diabetes Care

Authors：Lawrence A. Leiter; Robert P. Giugliano; Nicholas A. Marston; Gaetano De Ferrari; Jose C. Nicolau; Ajay K. Bhatia; Marcoli Cyrille; Jeong-Gun Park; Julia F. Kuder; Sabina A. Murphy; Lyrica Liu; Emileigh Walsh; Huei Wang; Andrej Dupina; Jorge Ferreira; Ioanna Gouni-Berthold; Henrik K. Jensen; Johanna Kuusisto; Daniel Pella; Naveed Sattar; Konstantinos P. Tsioufis; Dragos Vinereanu; Gabriel Paiva da Silva Lima; Marc S. Sabatine; Erin A. Bohula

Published date：2026-8-1

DOI：10.2337/dc26-0847

PDF link：https://diabetesjournals.org/car ... 881232/dc260847.pdf

Article link：https://doi.org/10.2337/dc26-0847

Article Source：American Diabetes Association。

Remark：

Post time 5 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Other] Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Other] Evolocumab in Patients With High-Risk Diabetes: Results From the VESALIUS-CV Trial Copy